December 4 & 5, 2018, Lille, France
« This round demonstrates that our economical mix model is successful» says François Boutignon, president of Aptys Pharmaceuticals. « Indeed, Aptys grew on the basis of its know-how and expertise dedicated to its pharmaceutical and biotech clients as well as to its own developments. We are glad to have found a financial partner coming from the pharmaceutical industry who recognized the pertinence of our strategy and agreed to follow us while we keep the control of corporate development».
Saint-Petersburg, July 19-21, 2018
29 Jan – 1 Feb 2018, Dubaï
COME AND MEET US AT : French pavilion in Za’abeel Hall 2. Z2.F53